News tagged with calcineurin inhibitors
Drug class linked to worse outcomes after transplant
(HealthDay)—Kidney transplant patients who receive mammalian target of rapamycin (mTOR) inhibitors after transplant have a greater probability of death or transplant failure than patients receiving calcineurin ...
Surgery
Oct 14, 2012 |
not rated yet |
0
Immunosuppressant switch cuts skin cancer post-transplant
(HealthDay) -- In kidney-transplant patients with at least one cutaneous squamous-cell carcinoma, switching immunosuppressants (from calcineurin inhibitors to sirolimus) is associated with increased skin cancer-free ...
Cancer
Jul 26, 2012 |
not rated yet |
0
Immune drug doesn't help kids with hard-to-treat kidney disorder
The drug rituximab, an antibody that targets the immune system and is often used to treat immune disorders such as lymphoma and arthritis, has recently emerged as a potential treatment for a childhood kidney disorder known ...
Diseases, Conditions, Syndromes
May 10, 2012 |
not rated yet |
0
Use of stem cells for adults receiving related donor kidney transplants appears to improve outcomes
Among patients with end-stage renal disease undergoing living-related kidney transplants, the use of bone-marrow derived mesenchymal (cells that can differentiate into a variety of cell types) stem cells instead of antibody ...
Medical research
Mar 20, 2012 |
not rated yet |
0
Time to stop giving toxic drugs to kidney transplant patients?
Patients who receive kidney transplants must take lifelong medications that, while preventing organ rejection, can also compromise other aspects of health. Immunosuppresive drugs called calcineurin inhibitors protect transplanted ...
Other
Sep 22, 2011 |
not rated yet |
0
Best post-transplant drug regimen identified for patients with new kidneys
For the thousands of patients who receive kidney transplants in the United States each year, preventing organ rejection without compromising other aspects of health requires a delicate balance of medications. Immunosuppresive ...
Other
Jul 29, 2011 |
not rated yet |
0
